Aaron Rosenberg - 01 Aug 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role: Chief Financial Officer
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: ONC
Transactions as of: 01 Aug 2025
Transactions value $: -$345,659
Form type: 4
Filing time: 05 Aug 2025, 17:16:07 UTC
Previous filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Rosenberg Aaron	Chief Financial Officer	C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND	/s/ Qing Nian, as Attorney-in-Fact	05 Aug 2025	0002031182

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONC	American Depositary Shares	Sale	-$346K	-1.19K	-100%	$290.47	0	01 Aug 2025	Direct	F1, F2
holding	ONC	Ordinary Shares						215K	01 Aug 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share represents 13 Ordinary Shares.
F2	The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Content

Each American Depositary Share represents 13 Ordinary Shares.

The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.